| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |